These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3279491

  • 1. New quinolones in the treatment of joint and bone infections.
    Desplaces N, Acar JF.
    Rev Infect Dis; 1988; 10 Suppl 1():S179-83. PubMed ID: 3279491
    [Abstract] [Full Text] [Related]

  • 2. Quinolones in the treatment of serious infections.
    Webster A, Gaya H.
    Rev Infect Dis; 1988; 10 Suppl 1():S225-33. PubMed ID: 3279496
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
    Dellamonica P, Bernard E, Etesse H, Garraffo R, Drugeon HB.
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1024-30. PubMed ID: 2515961
    [Abstract] [Full Text] [Related]

  • 4. The new quinolones and their combinations with other agents for therapy of severe infections.
    Desplaces N, Gutmann L, Carlet J, Guibert J, Acar JF.
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():25-39. PubMed ID: 3011726
    [Abstract] [Full Text] [Related]

  • 5. The comparative in-vitro activity of pefloxacin.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [Abstract] [Full Text] [Related]

  • 6. Quinolones in the treatment of bronchopulmonary infections.
    Thys JP.
    Rev Infect Dis; 1988 Apr; 10 Suppl 1():S212-7. PubMed ID: 3279495
    [Abstract] [Full Text] [Related]

  • 7. [New oral quinolone compounds in chronic bronchitis].
    Davies BI, Maesen FP, Teengs JP, Baur C.
    Infection; 1986 Apr; 14 Suppl 1():S73-8. PubMed ID: 2937739
    [Abstract] [Full Text] [Related]

  • 8. The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
    Fong IW.
    Clin Invest Med; 1989 Feb; 12(1):44-9. PubMed ID: 2646054
    [Abstract] [Full Text] [Related]

  • 9. Clinical use of the quinolones.
    Neu HC.
    Lancet; 1987 Dec 05; 2(8571):1319-22. PubMed ID: 2890913
    [No Abstract] [Full Text] [Related]

  • 10. 4-Quinolones in the treatment of infections of the central nervous system.
    Norrby SR.
    Rev Infect Dis; 1988 Dec 05; 10 Suppl 1():S253-5. PubMed ID: 3279498
    [Abstract] [Full Text] [Related]

  • 11. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R, Michéa-Hamzehpour M, Pechère JC.
    J Antimicrob Chemother; 1986 Apr 05; 17 Suppl B():29-39. PubMed ID: 2940214
    [Abstract] [Full Text] [Related]

  • 12. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov 05; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy: a way to limit emergence of resistance?
    Michéa-Hamzehpour M, Pechère JC, Marchou B, Auckenthaler R.
    Am J Med; 1986 Jun 30; 80(6B):138-42. PubMed ID: 3088999
    [Abstract] [Full Text] [Related]

  • 14. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H, Quentin C, de Barbeyrac B, Bebear C.
    Pathol Biol (Paris); 1988 May 30; 36(5):496-9. PubMed ID: 3136430
    [Abstract] [Full Text] [Related]

  • 15. The diffusion of pefloxacin into bone and the treatment of osteomyelitis.
    Dellamonica P, Bernard E, Etesse H, Garraffo R.
    J Antimicrob Chemother; 1986 Apr 30; 17 Suppl B():93-102. PubMed ID: 3086280
    [Abstract] [Full Text] [Related]

  • 16. In-vitro activity of pefloxacin compared with six other quinolones.
    Ligtvoet EE, Wickerhoff-Minoggio T.
    J Antimicrob Chemother; 1985 Oct 30; 16(4):485-90. PubMed ID: 3864776
    [Abstract] [Full Text] [Related]

  • 17. Quinolones.
    Shah PM.
    Prog Drug Res; 1987 Oct 30; 31():243-56. PubMed ID: 3326031
    [No Abstract] [Full Text] [Related]

  • 18. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H, Hayakawa I, Akimoto T.
    Yakushigaku Zasshi; 2003 Oct 30; 38(2):161-79. PubMed ID: 15143768
    [Abstract] [Full Text] [Related]

  • 19. Place of quinolones in the therapeutic armoury.
    Van Klingeren B.
    Pharm Weekbl Sci; 1986 Feb 21; 8(1):40-1. PubMed ID: 3960692
    [Abstract] [Full Text] [Related]

  • 20. Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
    Pechère JC, Marchou B, Michéa-Hamzehpour M, Auckenthaler R.
    J Antimicrob Chemother; 1986 Mar 21; 17 Suppl A():11-8. PubMed ID: 3086276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.